Financhill
Back

Cytokinetics Stock Predictions

Cytokinetics Stock Forecast

  • Over the next 52 weeks, Cytokinetics has on average historically risen by 11% based on the past 20 years of stock performance.
  • Cytokinetics has risen higher in 9 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 45%
  • Is Cytokinetics Stock Undervalued?
    The current Cytokinetics [CYTK] share price is $55.94. The Score for CYTK is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • CYTK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Cytokinetics Stock Go Up Next Year?

  • Over the next 52 weeks, Cytokinetics has on average historically risen by 11% based on the past 20 years of stock performance.

Cytokinetics Stock Rating

Buy
56
Cytokinetics (CYTK) is a Buy

Is Cytokinetics overpriced?

  • Cytokinetics has risen higher in 9 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 45%

Cytokinetics Stock Price History

Is CYTK stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTK is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cytokinetics.com

52-Week Data

52-Week High:
110.25
52-Week Low:
25.98

Prediction Charts

Market Cap:
6.58B
Price in USD:
55.94
Volume:
1.38M
Beta:
1.45

Technical Analysis

SMA50:
56.23
SMA100:
56.17
SMA200:
62.70
52-Wk Change:
65.16%

Stock Predictions

  • Is Cytokinetics stock public?
    Yes, Cytokinetics is a publicly traded company.
  • What is the Cytokinetics stock quote today?
    The Cytokinetics stock price is 55.94 USD today.
  • How to buy Cytokinetics stock online?
    You can buy Cytokinetics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Aug-29 55.99 57.39 58.68 55.21
Aug-30 57.94 57.03 57.98 56.28
Sep-3 56.72 54.51 57.80 54.22
Sep-4 54.29 54.89 55.05 53.16
Sep-5 55.50 55.98 56.87 54.68
Sep-6 56.19 54.11 56.36 53.21
Sep-9 54.31 55.83 56.26 54.17
Sep-10 56.03 54.15 56.19 53.80
Sep-11 53.69 53.77 54.06 52.85
Sep-12 53.78 54.03 55.41 53.51
Sep-13 54.34 55.88 56.20 54.08
Sep-16 56.46 56.75 57.03 55.44
Sep-17 57.00 56.16 57.48 53.31
Sep-18 56.95 55.94 57.76 53.88

Cytokinetics Earnings

Cytokinetics Earnings Report: Per Share Cytokinetics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Cytokinetics Forecast Revenue Growth

Cytokinetics Stock Analysis: Historical quarterly revenues per share for Cytokinetics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.49 per share, a decrease next quarter of $0.09 per share, a decrease this year of $0.28 per share, and an increase next year of $0.22 per share.

* Cytokinetics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.